Failed the trial but they will move ahead anyways
our goal of providing a safe and effective vaccine against Lyme disease,” said Annaliesa Anderson, Ph.D., Senior Vice President and Head of Vaccine Research and Development, Pfizer. https://www.pfizer.com/news/press-release/press-release-detail/phase-3-valor-lyme-disease-trial-valneva-and-pfizer Pfizer reportedly has a new “safe and effective” Lyme disease vaccine designed …